Industry Overview of Anesthesia and Respiratory Devices Market
Anesthesia and respiratory devices are specialized equipment that contributes to the improvement of patient care for those with acute and chronic respiratory diseases. They consist of dosing units, respiratory devices, and monitoring equipment. Anesthesia and respiratory devices enhance the effectiveness of diagnostic, therapeutic, and monitoring functions. They enable the automatic adjustment of inhalation and exhalation to meet the specific needs of the patient. As a result, anesthesia and respiratory devices find extensive applications across several healthcare settings such as hospitals, clinics, home care, ambulatory and dialysis centers, etc.
How Big Is the Anesthesia and Respiratory Devices Market?
The global anesthesia and respiratory devices market size reached US$ 43.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 71.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.02% during 2023-2028.
What Are the Growth Prospects and Trends in The Anesthesia and Respiratory Devices Industry?
The anesthesia and respiratory devices market is primarily driven by the increasing prevalence of respiratory disorders and other related ailments including chronic obstructive pulmonary disease (COPD), asthma, and tuberculosis among the general population. Moreover, the expanding geriatric population, who are more prone to these medical conditions, the rising airborne infections, and the escalating levels of air pollution are also positively influencing the market growth. Besides this, the inflating number of individuals who smoke and consume alcohol, owing to hectic lifestyles, and the surge in fatal road accidents leading to severe injuries are further fueling the demand for anesthesia and respiratory devices across countries. Additionally, the launch of favorable health insurance policies offering financial assistance for various medical treatments aiming to minimize healthcare expenses and the shifting preferences toward minimally invasive (MI) surgical procedures among patients and healthcare professionals are acting as significant growth-inducing factors. Apart from this, the elevating advancements in healthcare infrastructure, improved diagnostic technologies, and ongoing research and development (R&D) initiatives by key players to introduce novel devices will stimulate the anesthesia and respiratory devices market in the coming years.
What is included in market segmentation?
The report provides detailed segmentation of the global anesthesia and respiratory devices market based on based on product type, end user and region.
Breakup by Product Type:
- Anesthesia Devices
- Anesthesia Delivery Machines
- Anesthesia Disposables and Accessories
- Anesthesia Monitors
- Anesthesia Information Management Systems
- Respiratory Devices
- Therapeutic Devices
- Masks
- Ventilators
- Nebulizers
- Humidifiers
- Oxygen concentrators
- Inhalers
- Reusable Resuscitators
- Nitric Oxide Delivery Units
- Capnographs
- Gas Analyzers
- Oxygen Hoods
- Monitoring Devices
- Diagnostic Devices
- Spirometers
- Polysomnography (PSG) Devices
- Peak Flow Meters
- Consumables and Accessories
- Disposable Resuscitators
- Tracheostomy Tubes
- Nasal Cannulas
- Disposable Masks
- Others
Breakup by End User:
- Hospitals
- Clinics
- Homecare Settings
- Ambulatory Service Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report provides a comprehensive analysis of the industry key players listed below:
3M Company, Becton, Dickinson and Company, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, GE HealthCare (General Electric), Getinge AB, Hamilton Medical (Hamilton Bonaduz AG), ICU Medical Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, SunMed LLC and Teleflex Incorporated.